AAP
INBX icon

Arax Advisory Partners’s Inhibrx INBX Stock Holding History

Arax Advisory Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92K Buy
+73
New +$7.31K ﹤0.01% 4495
2025
Q4 		– Sell
-75
Closed -$2.53K – 4297
2025
Q3 		$2.53K Buy
+75
New +$1.85K ﹤0.01% 3058
2024
Q4 		– Sell
-10
Closed -$157 – 2571
2024
Q3 		$157 Hold
10
– – ﹤0.01% 2531
2024
Q2 		$142 Buy
+10
New +$156 ﹤0.01% 2465

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arax Advisory Partners's INBX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Inhibrx (INBX) in Q2 2026: 73 shares worth $6.92K. The stake represents ﹤0.01% of the portfolio and ranks #4495 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in INBX as recently as Q3 2025.

Arax Advisory Partners first reported a position in INBX in Q2 2024 and has held it in 4 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Arax Advisory Partners held 73 shares of Inhibrx worth $6.92K as of Q2 2026.
  • Inhibrx was a new Arax Advisory Partners position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4495 holding.
  • Arax Advisory Partners first reported a position in Inhibrx in Q2 2024 and has held it in 4 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.